In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

Discover how early CMC, process optimization, and formulation strategy drive scalable, commercially viable drugs.

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

At Fast Company and Johns Hopkins University's World Changing Ideas Summit in November, leaders shared what's top of mind for ...

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...

Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.

For decades, the process of drug discovery has been a prolonged, costly, and unpredictable endeavor — an effort that ...

In this part 3 of our three-part interview, Stenberg explores the evolving manufacturing paradigm in the pharmaceutical ...

On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Reshaping the Global Drug Development Landscape with the Industry's Only Natively AI-Powered Omnimodal Foundation Model for ...

One of the major promises of artificial intelligence (AI) is its role in speeding up drug discovery. AI can process massive ...